oxcarbazepine has been researched along with 10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 2 (22.22) | 18.2507 |
2000's | 3 (33.33) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boas, J; Dam, M; Flesch, G; Jensen, PK; Jórgensen, L; Mogensen, PH; Vesterager, A | 1 |
Paar, WD; von Unruh, GE | 1 |
Bittencourt, PR | 1 |
Kumps, A; Mardens, Y | 1 |
Aldigier, JC; Darragon, T; Godbillon, J; Hillion, D; Jungers, P; Kourilsky, O; Lecaillon, JB; Menard, F; Meyer, P; Rouan, MC | 1 |
Guénault, N; Odou, P; Robert, H | 1 |
Divanoglou, D; Gabrieli, C; Kanaze, FI; Kazis, D; Kimiskidis, V; Niopas, I; Spanakis, M | 1 |
Corso, G; D'Apolito, O; Paglia, G | 1 |
Brezina, E; Meyer, J; Mückter, H; Prasse, C; Ternes, TA | 1 |
3 trial(s) available for oxcarbazepine and 10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide
Article | Year |
---|---|
Gas chromatographic/mass spectrometric assays for oxcarbazepine and its main metabolites, 10-hydroxy-carbazepine and carbazepine-10,11-trans-diol.
Topics: Anticonvulsants; Biological Availability; Carbamazepine; Clinical Trials as Topic; Epilepsy; Gas Chromatography-Mass Spectrometry; Humans; Oxcarbazepine | 1986 |
Oxcarbazepine and spasticity: further observations.
Topics: Adult; Anticonvulsants; Carbamazepine; Clinical Trials as Topic; Double-Blind Method; Epilepsy; Female; Humans; Male; Middle Aged; Muscle Spasticity; Oxcarbazepine | 1988 |
Development and validation of a high performance liquid chromatographic method for the determination of oxcarbazepine and its main metabolites in human plasma and cerebrospinal fluid and its application to pharmacokinetic study.
Topics: Acetonitriles; Amines; Anticonvulsants; Biotransformation; Buffers; Calibration; Carbamazepine; Chromatography, High Pressure Liquid; Drug Monitoring; Epilepsy; Guidelines as Topic; Humans; Linear Models; Oxcarbazepine; Phosphates; Potassium Compounds; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Solvents; Spectrophotometry, Ultraviolet | 2007 |
6 other study(ies) available for oxcarbazepine and 10,11-dihydro-10,11-dihydroxy-5h-dibenzazepine-5-carboxamide
Article | Year |
---|---|
Effects of dextropropoxyphene on the steady-state kinetics of oxcarbazepine and its metabolites.
Topics: Administration, Oral; Adolescent; Adult; Aged; Anticonvulsants; Carbamazepine; Dextropropoxyphene; Dose-Response Relationship, Drug; Drug Therapy, Combination; Epilepsy; Female; Humans; Male; Middle Aged; Oxcarbazepine; Trigeminal Neuralgia | 1992 |
Cross-reactivity assessment of oxcarbazepine and its metabolites in the EMIT assay of carbamazepine plasma levels.
Topics: Biotransformation; Carbamazepine; Cross Reactions; Humans; Immunoenzyme Techniques; Oxcarbazepine | 1986 |
The effect of renal impairment on the pharmacokinetics of oxcarbazepine and its metabolites.
Topics: Adult; Aged; Anticonvulsants; Carbamazepine; Female; Humans; Kidney Diseases; Male; Middle Aged; Oxcarbazepine | 1994 |
Increase in dihydroxycarbamazepine serum levels in patients co-medicated with oxcarbazepine and lamotrigine.
Topics: Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Humans; Lamotrigine; Oxcarbazepine; Retrospective Studies; Triazines | 2003 |
The accuracy of oxcarbazepine (OXC) quantification by a liquid chromatography/tandem mass spectrometry method is influenced by the ion source fragmentation of its metabolite trans-diol-carbazepine (DHD).
Topics: Anticonvulsants; Carbamazepine; Chromatography, High Pressure Liquid; Oxcarbazepine; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2007 |
Investigation and risk evaluation of the occurrence of carbamazepine, oxcarbazepine, their human metabolites and transformation products in the urban water cycle.
Topics: Carbamazepine; Chromatography, Liquid; Cities; Filtration; Groundwater; Humans; Mass Spectrometry; Oxcarbazepine; Risk Assessment; Waste Disposal, Fluid; Wastewater; Water Cycle; Water Pollutants, Chemical | 2017 |